rs3733895

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000046.5(ARSB):​c.313-26T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,611,296 control chromosomes in the GnomAD database, including 101,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7526 hom., cov: 32)
Exomes 𝑓: 0.35 ( 93571 hom. )

Consequence

ARSB
NM_000046.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.401

Publications

13 publications found
Variant links:
Genes affected
ARSB (HGNC:714): (arylsulfatase B) Arylsulfatase B encoded by this gene belongs to the sulfatase family. The arylsulfatase B homodimer hydrolyzes sulfate groups of N-Acetyl-D-galactosamine, chondriotin sulfate, and dermatan sulfate. The protein is targeted to the lysozyme. Mucopolysaccharidosis type VI is an autosomal recessive lysosomal storage disorder resulting from a deficiency of arylsulfatase B. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Dec 2016]
ARSB Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 5-78969218-A-G is Benign according to our data. Variant chr5-78969218-A-G is described in ClinVar as Benign. ClinVar VariationId is 254739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.367 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000046.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARSB
NM_000046.5
MANE Select
c.313-26T>C
intron
N/ANP_000037.2
ARSB
NM_198709.3
c.313-26T>C
intron
N/ANP_942002.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARSB
ENST00000264914.10
TSL:1 MANE Select
c.313-26T>C
intron
N/AENSP00000264914.4
ARSB
ENST00000396151.7
TSL:1
c.313-26T>C
intron
N/AENSP00000379455.3
ARSB
ENST00000565165.2
TSL:1
c.313-26T>C
intron
N/AENSP00000456339.2

Frequencies

GnomAD3 genomes
AF:
0.301
AC:
45813
AN:
151976
Hom.:
7521
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.438
Gnomad AMR
AF:
0.315
Gnomad ASJ
AF:
0.402
Gnomad EAS
AF:
0.226
Gnomad SAS
AF:
0.267
Gnomad FIN
AF:
0.386
Gnomad MID
AF:
0.360
Gnomad NFE
AF:
0.371
Gnomad OTH
AF:
0.328
GnomAD2 exomes
AF:
0.324
AC:
80995
AN:
250196
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.155
Gnomad AMR exome
AF:
0.296
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.216
Gnomad FIN exome
AF:
0.379
Gnomad NFE exome
AF:
0.370
Gnomad OTH exome
AF:
0.344
GnomAD4 exome
AF:
0.354
AC:
516648
AN:
1459202
Hom.:
93571
Cov.:
31
AF XY:
0.353
AC XY:
256015
AN XY:
726150
show subpopulations
African (AFR)
AF:
0.154
AC:
5153
AN:
33408
American (AMR)
AF:
0.301
AC:
13441
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
10495
AN:
26120
East Asian (EAS)
AF:
0.258
AC:
10215
AN:
39662
South Asian (SAS)
AF:
0.269
AC:
23176
AN:
86174
European-Finnish (FIN)
AF:
0.381
AC:
20332
AN:
53392
Middle Eastern (MID)
AF:
0.335
AC:
1892
AN:
5652
European-Non Finnish (NFE)
AF:
0.371
AC:
411481
AN:
1109794
Other (OTH)
AF:
0.339
AC:
20463
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
18085
36170
54254
72339
90424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12820
25640
38460
51280
64100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.301
AC:
45840
AN:
152094
Hom.:
7526
Cov.:
32
AF XY:
0.301
AC XY:
22414
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.161
AC:
6678
AN:
41530
American (AMR)
AF:
0.316
AC:
4823
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
1395
AN:
3468
East Asian (EAS)
AF:
0.227
AC:
1169
AN:
5160
South Asian (SAS)
AF:
0.267
AC:
1289
AN:
4820
European-Finnish (FIN)
AF:
0.386
AC:
4081
AN:
10560
Middle Eastern (MID)
AF:
0.373
AC:
109
AN:
292
European-Non Finnish (NFE)
AF:
0.371
AC:
25204
AN:
67958
Other (OTH)
AF:
0.328
AC:
693
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1604
3208
4813
6417
8021
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.343
Hom.:
31539
Bravo
AF:
0.291
Asia WGS
AF:
0.251
AC:
874
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mucopolysaccharidosis type 6 Benign:1
Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
12
DANN
Benign
0.76
PhyloP100
0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3733895; hg19: chr5-78265041; COSMIC: COSV53720346; API